Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival

  • Jason G. Kettle
    Oncology Innovative Medicines Unit, AstraZeneca, 35S47 Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom
  • Husam Alwan
    Oncology Innovative Medicines Unit, AstraZeneca, 35S47 Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom
  • Michal Bista
    Oncology Innovative Medicines Unit, AstraZeneca, Unit 310, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom
  • Jason Breed
    Discovery Sciences, AstraZeneca, Unit 310, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom
  • Nichola L. Davies
    Oncology Innovative Medicines Unit, AstraZeneca, Unit 310, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom
  • Kay Eckersley
    Discovery Sciences, AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom
  • Shaun Fillery
    Oncology Innovative Medicines Unit, AstraZeneca, Unit 310, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom
  • Kevin M. Foote
    Oncology Innovative Medicines Unit, AstraZeneca, Unit 310, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom
  • Louise Goodwin
    Oncology Innovative Medicines Unit, AstraZeneca, 35S47 Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom
  • David R. Jones
    Oncology Innovative Medicines Unit, AstraZeneca, 35S47 Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom
  • Helena Käck
    Discovery Sciences, AstraZeneca, Pepparedsleden 1, 431 83 Mölndal, Sweden
  • Alan Lau
    Oncology Innovative Medicines Unit, AstraZeneca, 35S47 Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom
  • J. Willem M. Nissink
    Oncology Innovative Medicines Unit, AstraZeneca, Unit 310, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom
  • Jon Read
    Discovery Sciences, AstraZeneca, Unit 310, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom
  • James S. Scott
    Oncology Innovative Medicines Unit, AstraZeneca, Unit 310, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom
  • Ben Taylor
    Discovery Sciences, AstraZeneca, Unit 310, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom
  • Graeme Walker
    Discovery Sciences, AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom
  • Lisa Wissler
    Discovery Sciences, AstraZeneca, Pepparedsleden 1, 431 83 Mölndal, Sweden
  • Marta Wylot
    Oncology Innovative Medicines Unit, AstraZeneca, Unit 310, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom

この論文をさがす

収録刊行物

被引用文献 (10)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ